BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 15302897)

  • 1. Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays.
    Nouzova M; Holtan N; Oshiro MM; Isett RB; Munoz-Rodriguez JL; List AF; Narro ML; Miller SJ; Merchant NC; Futscher BW
    J Pharmacol Exp Ther; 2004 Dec; 311(3):968-81. PubMed ID: 15302897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
    Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
    Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatin states of developmentally-regulated genes revealed by DNA and histone methylation patterns in zebrafish embryos.
    Lindeman LC; Winata CL; Aanes H; Mathavan S; Alestrom P; Collas P
    Int J Dev Biol; 2010; 54(5):803-13. PubMed ID: 20336603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration.
    Bhakat KK; Mitra S
    Carcinogenesis; 2003 Aug; 24(8):1337-45. PubMed ID: 12807730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A distinct epigenetic signature at targets of a leukemia protein.
    Rossetti S; Hoogeveen AT; Liang P; Stanciu C; van der Spek P; Sacchi N
    BMC Genomics; 2007 Feb; 8():38. PubMed ID: 17266773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
    Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
    Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia.
    Strathdee G; Sim A; Soutar R; Holyoake TL; Brown R
    Carcinogenesis; 2007 Feb; 28(2):299-309. PubMed ID: 16861263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epigenetic regulation of expression of retinoic acid receptor beta gene in leukemia cell].
    Meng YS; Ma XX; Meng XQ; Wei R; Liu W; Ai GW; Zhang YX
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3406-10. PubMed ID: 18476539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C/EBPα and PU.1 are involved in distinct differentiation responses of acute promyelocytic leukemia HL-60 and NB4 cells via chromatin remodeling.
    Savickiene J; Treigyte G; Vistartaite G; Tunaitis V; Magnusson KE; Navakauskiene R
    Differentiation; 2011 Jan; 81(1):57-67. PubMed ID: 20864248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of tumor cells with histone deacetylase inhibitors results in altered recruitment of methyl-CpG binding proteins to a methylated CpG island.
    Koizume S; Tachibana K; Shiraishi M
    Biol Chem; 2003 May; 384(5):787-90. PubMed ID: 12817475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
    Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
    Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats.
    Ke X; Lei Q; James SJ; Kelleher SL; Melnyk S; Jernigan S; Yu X; Wang L; Callaway CW; Gill G; Chan GM; Albertine KH; McKnight RA; Lane RH
    Physiol Genomics; 2006 Mar; 25(1):16-28. PubMed ID: 16380407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo.
    Fazi F; Travaglini L; Carotti D; Palitti F; Diverio D; Alcalay M; McNamara S; Miller WH; Lo Coco F; Pelicci PG; Nervi C
    Oncogene; 2005 Mar; 24(11):1820-30. PubMed ID: 15688037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells.
    Shen Y; Chow J; Wang Z; Fan G
    Hum Mol Genet; 2006 Sep; 15(17):2623-35. PubMed ID: 16870691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-expression of DNA methylation-silenced CD44 gene in a resistant NB4 cell line: rescue of CD44-dependent cell death by cAMP.
    Abecassis I; Maes J; Carrier JL; Hillion J; Goodhardt M; Medjber K; Wany L; Lanotte M; Karniguian A
    Leukemia; 2008 Mar; 22(3):511-20. PubMed ID: 18094716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical application of targeting cancer through histone acetylation and hypomethylation.
    Gilbert J; Gore SD; Herman JG; Carducci MA
    Clin Cancer Res; 2004 Jul; 10(14):4589-96. PubMed ID: 15269129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
    Sadikovic B; Andrews J; Rodenhiser DI
    Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.